Literature DB >> 26697837

Erk5 contributes to maintaining the balance of cellular nucleotide levels and erythropoiesis.

Maria Angulo-Ibáñez1, Xavier Rovira-Clavé1, Alba Granados-Jaén1, Bradley Downs2, Yeong C Kim2, San Ming Wang2, Manuel Reina1, Enric Espel1,3.   

Abstract

An adequate supply of nucleotides is essential for accurate DNA replication, and inappropriate deoxyribonucleotide triphosphate (dNTP) concentrations can lead to replication stress, a common source of DNA damage, genomic instability and tumourigenesis. Here, we provide evidence that Erk5 is necessary for correct nucleotide supply during erythroid development. Mice with Erk5 knockout in the haematopoietic lineage showed impaired erythroid development in bone marrow, accompanied by altered dNTP levels and increased DNA mutagenesis in erythroid progenitors as detected by exome sequencing. Moreover, Erk5-depleted leukemic Jurkat cells presented a marked sensitivity to thymidine-induced S phase stalling, as evidenced by increased H2AX phosphorylation and apoptosis. The increase in thymidine sensitivity correlated with a higher dTTP/dCTP ratio. These results indicate that Erk5 is necessary to maintain the balance of nucleotide levels, thus preventing dNTP misincorporation and DNA damage in proliferative erythroid progenitors and leukemic Jurkat T cells.

Entities:  

Keywords:  dNTP metabolism; erythroid development; erythropoiesis; replication stress; thymidine

Mesh:

Substances:

Year:  2015        PMID: 26697837      PMCID: PMC4825733          DOI: 10.1080/15384101.2015.1120914

Source DB:  PubMed          Journal:  Cell Cycle        ISSN: 1551-4005            Impact factor:   4.534


  59 in total

1.  Multisite phosphorylation of Erk5 in mitosis.

Authors:  Elena Díaz-Rodríguez; Atanasio Pandiella
Journal:  J Cell Sci       Date:  2010-08-24       Impact factor: 5.285

2.  VarScan 2: somatic mutation and copy number alteration discovery in cancer by exome sequencing.

Authors:  Daniel C Koboldt; Qunyuan Zhang; David E Larson; Dong Shen; Michael D McLellan; Ling Lin; Christopher A Miller; Elaine R Mardis; Li Ding; Richard K Wilson
Journal:  Genome Res       Date:  2012-02-02       Impact factor: 9.043

3.  Aberrant p53 protein expression and function in a panel of hematopoietic cell lines with different p53 mutations.

Authors:  Shimeru Kamihira; Chiharu Terada; Daisuke Sasaki; Katsunori Yanagihara; Kunihiro Tsukasaki; Hiroo Hasegawa; Yasuaki Yamada
Journal:  Eur J Haematol       Date:  2008-01-29       Impact factor: 2.997

4.  Deoxycytidine kinase from human leukemic spleen: preparation and characteristics of homogeneous enzyme.

Authors:  C Bohman; S Eriksson
Journal:  Biochemistry       Date:  1988-06-14       Impact factor: 3.162

5.  Requirement for deoxycytidine kinase in T and B lymphocyte development.

Authors:  Gerald Toy; Wayne R Austin; Hsiang-I Liao; Donghui Cheng; Arun Singh; Dean O Campbell; Tomo-o Ishikawa; Lynn W Lehmann; Nagichettiar Satyamurthy; Michael E Phelps; Harvey R Herschman; Johannes Czernin; Owen N Witte; Caius G Radu
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-31       Impact factor: 11.205

6.  Bmk1/Erk5 is required for cell proliferation induced by epidermal growth factor.

Authors:  Y Kato; R I Tapping; S Huang; M H Watson; R J Ulevitch; J D Lee
Journal:  Nature       Date:  1998-10-15       Impact factor: 49.962

7.  Thymidylate synthase as an oncogene: a novel role for an essential DNA synthesis enzyme.

Authors:  Lambratu Rahman; Donna Voeller; Monzur Rahman; Stan Lipkowitz; Carmen Allegra; J Carl Barrett; Frederic J Kaye; Maria Zajac-Kaye
Journal:  Cancer Cell       Date:  2004-04       Impact factor: 31.743

Review 8.  Transcriptional regulation of the p21((WAF1/CIP1)) gene.

Authors:  A L Gartel; A L Tyner
Journal:  Exp Cell Res       Date:  1999-02-01       Impact factor: 3.905

9.  Major deletions in the gene encoding the p53 tumor antigen cause lack of p53 expression in HL-60 cells.

Authors:  D Wolf; V Rotter
Journal:  Proc Natl Acad Sci U S A       Date:  1985-02       Impact factor: 11.205

10.  The yeast mitogen-activated protein kinase Slt2 is involved in the cellular response to genotoxic stress.

Authors:  María Soriano-Carot; M Carmen Bañó; J Carlos Igual
Journal:  Cell Div       Date:  2012-02-01       Impact factor: 5.130

View more
  5 in total

1.  ERK5 kinase activity is dispensable for cellular immune response and proliferation.

Authors:  Emme C K Lin; Christopher M Amantea; Tyzoon K Nomanbhoy; Helge Weissig; Junichi Ishiyama; Yi Hu; Shyama Sidique; Bei Li; John W Kozarich; Jonathan S Rosenblum
Journal:  Proc Natl Acad Sci U S A       Date:  2016-09-27       Impact factor: 11.205

2.  Efficient terminal erythroid differentiation requires the APC/C cofactor Cdh1 to limit replicative stress in erythroblasts.

Authors:  Myriam Cuadrado; Javier Garzón; Sergio Moreno; Irene García-Higuera
Journal:  Sci Rep       Date:  2022-06-21       Impact factor: 4.996

3.  ATM meets ERK5.

Authors:  Maria Angulo-Ibáñez; Xavier Rovira-Clavé; Enric Espel
Journal:  Aging (Albany NY)       Date:  2017-02-27       Impact factor: 5.682

4.  Absence of ERK5/MAPK7 delays tumorigenesis in Atm-/- mice.

Authors:  Alba Granados-Jaén; Maria Angulo-Ibáñez; Xavier Rovira-Clavé; Celina Paola Vasquez Gamez; Francesc X Soriano; Manuel Reina; Enric Espel
Journal:  Oncotarget       Date:  2016-11-15

5.  MicroRNA-143 targets ERK5 in granulopoiesis and predicts outcome of patients with acute myeloid leukemia.

Authors:  Jens-Uwe Hartmann; Daniela Bräuer-Hartmann; Miroslava Kardosova; Alexander A Wurm; Franziska Wilke; Cindy Schödel; Dennis Gerloff; Christiane Katzerke; Rosanna Krakowsky; Carolina Yaeko Namasu; Marius Bill; Sebastian Schwind; Carsten Müller-Tidow; Dietger Niederwieser; Meritxell Alberich-Jorda; Gerhard Behre
Journal:  Cell Death Dis       Date:  2018-07-26       Impact factor: 8.469

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.